Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

Abstract Background Desmoid fibromatosis (DF) is a rare fibroblastic proliferation that was historically treated with surgery. We report (a) outcomes using low‐dose chemotherapy, methotrexate (MTX), and vinorelbine (VNL) for patients with progressing disease (PD) and (b) whether tumor volume (Vtumor...

Full description

Bibliographic Details
Main Authors: Katrina M. Ingley, Sally M. Burtenshaw, Nicole C. Theobalds, Lawrence M. White, Martin E. Blackstein, Rebecca A. Gladdy, Seng Thipphavong, Abha A. Gupta
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Cancer Medicine
Subjects:
aggressive fibromatosis
desmoid fibromatosis
methotrexate/vinorelbine chemotherapy
MR imaging
T2 signal
tumor volume
Online Access:https://doi.org/10.1002/cam4.2374

Internet

https://doi.org/10.1002/cam4.2374

Similar Items